Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2012
05/30/2012CN102475742A 灭活罂粟籽榨油后残渣及其提取物作为制备镇痛药物的应用 After inactivation of poppy seed oil extraction residue and extract as an application of the preparation of analgesic drugs
05/30/2012CN102475731A 治疗小儿(轮状病毒、痢疾及疟疾)疾病分子苗药原料 Treatment of children (rotavirus, diarrhea and malaria) disease molecular Miao medicine raw materials
05/30/2012CN102475715A 戒烟贴 The patch
05/30/2012CN102475700A Daidzein concentrated solution and special diluent agent thereof
05/30/2012CN102475699A 益母草碱在制备防治帕金森病药物中的用途 Leonurine prevention of Parkinson's disease in the preparation of a medicament for
05/30/2012CN102475697A 注射用门冬氨酸鸟氨酸的制备 Injectable preparation with ornithine aspartate
05/30/2012CN102475692A Transdermal patch preventing rasagiline from volatilizing
05/30/2012CN102475682A 小檗碱脂质体及其制备方法 Berberine liposomes and its preparation method
05/30/2012CN102475666A Composite Chinese herbal medicine cosmetic with skin healing function
05/30/2012CN102475171A 一种解酒茶 One kind of hangover tea
05/30/2012CN102210789B Agilawood compound essential oil capable of improving sleeping
05/30/2012CN102204959B Medicament for treating epilepsy
05/30/2012CN102188521B Composition for relieving and neutralizing effect of alcohol
05/30/2012CN102125678B Chinese medicinal preparation for treating hysteria disease
05/30/2012CN102114195B Anti-drug capsule prepared from pure traditional Chinese medicines
05/30/2012CN102114024B Compound Cigu capsules for preventing migraine in menstrual period
05/30/2012CN102078383B Compound ginkgo leaf capsule and tablet preparation method
05/30/2012CN102028681B Application of peperphentonamine or salt thereof in preparing drug for preventing/treating encephalopathy
05/30/2012CN102018662B Method for preparing dihydroergotoxine mesilate injection
05/30/2012CN101991766B Medicament for facilitating sleep and preparation method and application thereof
05/30/2012CN101991638B Medicine composition for treating facial paralysis as well as preparation method and application thereof
05/30/2012CN101978975B Haematococcus extract preparation, and preparation method and use thereof
05/30/2012CN101972326B Medicinal preparation for relieving alcohol toxin
05/30/2012CN101972251B Use of hirsutine in preparing anti-addictive drug
05/30/2012CN101966194B New application of scutellarin and derivatives thereof
05/30/2012CN101961350B Preparation method of fishy smell-removed pearl powder
05/30/2012CN101953822B Venlafaxine hydrochloride controlled release tablets and preparation method thereof
05/30/2012CN101947249B Method for ultrasonic extraction of total saponins of rhizoma panacis majoris
05/30/2012CN101940610B Preparation method of astragalus extractive
05/30/2012CN101940419B Novel health-care pillow
05/30/2012CN101899074B Preparation method for monosialotetrahexosyl ganglioside and monosialotetrahexosyl ganglioside sodium injection or freeze-dried powder injection
05/30/2012CN101830848B Polyamine derivative as well as preparation method and application thereof
05/30/2012CN101829306B Traditional Chinese medicine composition for treating hemiplegia and preparation method thereof
05/30/2012CN101829282B Medicine for treating migraine wind-stasis syndrome and preparation process thereof
05/30/2012CN101824399B Method for inducing and differentiating into dopaminergic neuron from human amniotic sepithelial cell and application for separating obtained dopaminergic neuron
05/30/2012CN101810824B Chinese medicament for curing post-stroke hand-shoulder syndrome
05/30/2012CN101797279B Health care product with dealcoholic function
05/30/2012CN101781268B Isothiazole ketone substituted benzene dicarboxylic acid derivative and usage thereof in preparation of beta-secretase inhibitor
05/30/2012CN101773475B Preparation method of capsicine micro spheres
05/30/2012CN101723955B Method for preparing olanzapine
05/30/2012CN101712670B Preparation method and application of 3'8''-bis-apigenin type bis-flavonoid
05/30/2012CN101657418B Pyrrolidine derivatives as dual NK1/NK3 receptor antagonists
05/30/2012CN101647853B Application of Aidi preparation in preparing medicament for treating nervous system diseases
05/30/2012CN101646678B Heteroaryl derivative
05/30/2012CN101622012B Improved medicinal compositions comprising buprenorphine and nalmefene
05/30/2012CN101579379B Medicinal composition for treating senile dementia and preparation method thereof
05/30/2012CN101579344B Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
05/30/2012CN101563321B 4-(heterocyclyl)alkyl-n-(arylsulfonyl) indole compounds and their use as 5-ht6 ligands
05/30/2012CN101563320B [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders
05/30/2012CN101550119B Aryl (ethanoic) propanoic acid ascorbyl ester, preparation method thereof and medicament containing same
05/30/2012CN101486768B Antigen protein for treating Alzheimer's disease and protein gene
05/30/2012CN101461873B Chinese patent medicine for treating facial paralysis and preparation method thereof
05/30/2012CN101460468B 2-pyrazinecarboxamide derivatives
05/30/2012CN101455825B Erchen decoction preparation method
05/30/2012CN101421243B Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
05/30/2012CN101415678B Benzo[F]isoindol-2-ylphenyl acetic acid derivatives as EP4 receptor agonists
05/30/2012CN101400657B Polycyclic cinnamide derivative
05/30/2012CN101375928B Pharmaceutical combination for preventing birth-defect and improving memory
05/30/2012CN101375926B Pharmaceutical combination for preventing birth-defect and improving memory
05/30/2012CN101366871B Medicament composition for preventing birth defect and improving memory
05/30/2012CN101366870B Medicament composition for preventing birth defect and improving memory
05/30/2012CN101366869B Medicament composition for preventing birth defect and improving memory
05/30/2012CN101366867B Medicament composition for preventing birth defect and improving memory
05/30/2012CN101366778B Medicament composition for preventing birth defection and improving memory
05/30/2012CN101317819B Rotigotine flexible liposome and transdermal drug administration formulation for hydrophilic substance
05/30/2012CN101313752B Method for preparing naturally cooked panax ginseng
05/30/2012CN101288475B Production method of flavor panax ginseng
05/30/2012CN101267819B Combination of a long-acting hypnotic agent and a short-acting hypnotic agent
05/30/2012CN101254185B Use of cyclic enol ether terpenoid for producing promotive neurocyte proliferate and differentiation medicament
05/30/2012CN101248044B Novel indole compounds
05/30/2012CN101061105B Potentiators of glutamate receptors
05/30/2012CN101035541B Neuroprotective effect of solubilized UDCA in focal ischemic model
05/29/2012US8188275 hydrolase enzyme inhibors such as 2-(6-Chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
05/29/2012US8188259 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration
05/29/2012US8188216 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents
05/29/2012US8188146 Highly purified ethyl EPA and other EPA derivatives
05/29/2012US8188107 T-614 is a cyclooxygenase-2 inhibitor; reduced plasma concentrations of an opioid analgesic, while still providing effective pain management; side effect reduction
05/29/2012US8188069 Azepine derivatives as gamma-secretase inhibitors
05/29/2012US8188046 Amyloid beta peptides and methods of use
05/29/2012US8187612 Neuromuscular disorders
05/29/2012CA2583876C A transmucosal veterinary composition comprising detomidine
05/29/2012CA2555624C Thioamide compounds or salts thereof and cytokine production inhibitors containing the same
05/29/2012CA2542140C Crystalline forms of {2-[1-(3,5-bis-trifluoromethylbenzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
05/29/2012CA2531210C Imidazole derivatives and their use in the treatment of mglur5 receptor mediated disorders
05/29/2012CA2529561C Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
05/29/2012CA2516056C Aprotinin and analogs as carriers across the blood-brain barrier
05/29/2012CA2496585C Novel 1,4-diazabicycloalkane derivatives, their preparation and use
05/29/2012CA2482499C Aerosol containing a particulate active substance
05/29/2012CA2481036C (3z)-(3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
05/29/2012CA2446738C Abuse-resistant opioid dosage form
05/29/2012CA2440767C Novel neurotrophic factors
05/29/2012CA2426393C Crystalline forms of venlafaxine hydrochloride
05/29/2012CA2417389C Therapeutic polyesters and polyamides
05/29/2012CA2389429C Compositions and methods for counteracting effects of reactive oxygen species and free radicals
05/29/2012CA2379388C Immunoglobulin fusion proteins
05/29/2012CA2268258C Single-chain multiple antigen-binding molecule, its preparation and use
05/24/2012WO2012068516A2 Low dose cannabinoid medicaments
05/24/2012WO2012068470A2 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
05/24/2012WO2012068332A2 Methods for treating early stage or mild neurological disorders
05/24/2012WO2012068209A2 Bisthiazole inhibitors of pro-matrix metalloproteinase activation
1 ... 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 ... 1833